These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8422222

  • 1. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E, Rickels K, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [Abstract] [Full Text] [Related]

  • 2. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
    Rickels K, Schweizer E, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
    [Abstract] [Full Text] [Related]

  • 3. Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
    Mavissakalian M, Perel JM.
    Arch Gen Psychiatry; 1992 Apr; 49(4):318-23. PubMed ID: 1558466
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E, Patterson W, Rickels K, Rosenthal M.
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [Abstract] [Full Text] [Related]

  • 6. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 7. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
    Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF.
    J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
    [Abstract] [Full Text] [Related]

  • 8. Maintenance drug therapy of panic disorder.
    Curtis GC, Massana J, Udina C, Ayuso JL, Cassano GB, Perugi G.
    J Psychiatr Res; 1993 Apr; 27 Suppl 1():127-42. PubMed ID: 8145175
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
    Br J Psychiatry; 1992 Feb; 160():191-202; discussion 202-5. PubMed ID: 1540759
    [Abstract] [Full Text] [Related]

  • 12. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD.
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
    Mavissakalian M, Perel JM.
    Am J Psychiatry; 1992 Aug; 149(8):1053-7. PubMed ID: 1636805
    [Abstract] [Full Text] [Related]

  • 14. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Aug; 241(3):151-8. PubMed ID: 1790160
    [Abstract] [Full Text] [Related]

  • 15. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    Ballenger JC, Burrows GD, DuPont RL, Lesser IM, Noyes R, Pecknold JC, Rifkin A, Swinson RP.
    Arch Gen Psychiatry; 1988 May; 45(5):413-22. PubMed ID: 3282478
    [Abstract] [Full Text] [Related]

  • 16. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K.
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S.
    Acta Psychiatr Scand Suppl; 1991 May; 365():18-27. PubMed ID: 1862730
    [Abstract] [Full Text] [Related]

  • 18. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 May; 241(1):22-30. PubMed ID: 1832302
    [Abstract] [Full Text] [Related]

  • 19. The structure of phobias in panic disorder.
    Argyle N, Solyom C, Solyom L.
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [Abstract] [Full Text] [Related]

  • 20. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
    Sheikh JI, Swales PJ.
    Int J Psychiatry Med; 1999 Sep; 29(1):107-17. PubMed ID: 10376237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.